Expands proprietary ExactechGPS technology
to the shoulder market for use with industry-leading Equinoxe®
Shoulder System
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder and spine,
today announced positive surgeon feedback on first surgeries
performed with the ExactechGPS® Guided Personalized Surgery
system’s new Total Shoulder Application, which combines
preoperative planning with intraoperative computer-assisted
technology. Pierre-Henri Flurin, MD, a shoulder specialist at the
Clinique du Sport in Bordeaux-Mérignac, France, performed both an
anatomic and a reverse total shoulder replacement using Equinoxe®
Shoulder System implants and instruments.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20160929006357/en/
Dr. Pierre-Henri Flurin, MD, a shoulder
specialist at the Clinique du Sport in Bordeaux-Mérignac, France,
performed both an anatomic and a reverse total shoulder replacement
using Exactech's Equinoxe® Shoulder System implants and
instruments. (Photo: Business Wire)
"Our goal is to offer improved accuracy and precision in the
placement and orientation of the Equinoxe implants,” said Dr.
Flurin. “I was able to plan the case in advance through a virtual
simulation and then execute that plan while visualizing the 3-D
anatomy in real time, making adjustments based on assessments
during surgery. Exactech’s design teams have developed
innovative shoulder implants designed to preserve bone and overcome
challenges; this new technology is the perfect complement to those
implants.”
“In collaboration with our team of engineers located in Florida
and France, Dr. Flurin and the rest of the design team brought
brilliant expertise to our effort,” said Darin Johnson, Vice
President of Marketing, Extremities. “Visualizing the glenoid vault
in real time and adjusting the implant orientation to the unique
anatomy of the patient should help surgeons improve patient
outcomes, which is what we come to work every day to do.”
The shoulder application focuses on guiding the preparation of
the glenoid in shoulder arthroplasty. There is wide variation in
the position and orientation of glenoid implants because of limited
exposure and poor operative landmarks, and studies show that
inaccurate placement of the glenoid component has been linked with
increased stresses in the implants1, early loosening and poor
outcomes.2 The goal of the new ExactechGPS Total Shoulder
Application is to allow surgeons to avoid those issues, ultimately
providing longer implant survivorship.
Exactech worked closely with a design team of experienced upper
extremity specialists to develop this system: Emilie Cheung, MD,
Stanford University Department of Orthopaedics (Palo Alto, Calif.);
Pierre-Henri Flurin, MD, Clinique du Sport (Bordeaux-Mérignac,
France); Richard Jones, MD, Southeastern Sports Medicine
(Asheville, N.C.); Moby Parsons, MD, Seacoast Orthopedics and
Sports Medicine (Somersworth, N.H.); Paul Saadi, MD, Dallas Bone
and Joint Clinic (Dallas, Texas); Thomas Wright, MD, University of
Florida Department of Orthopaedics and Rehabilitation (Gainesville,
Fla.); and Joseph Zuckerman, MD, NYU Hospital for Joint Diseases
(New York, N.Y.).
The ExactechGPS Total Shoulder Application is being piloted in
Europe and is currently undergoing premarket review by the
FDA.*
About ExactechGPS
ExactechGPS combines surgeon expertise with an advanced computer
system to perform the patient’s surgery with a goal of improved
accuracy and precision. Personalized for a patient’s unique bone
structure and anatomy, ExactechGPS is designed to allow surgeons to
decide where to remove bone and place the implant in the optimal
position. Exactech first introduced ExactechGPS to surgeons in the
United States for knees, and has since broadened its reach by
providing medical education and supporting surgeries in more than
11 countries. The technology has steadily gained market acceptance
and worldwide reach.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech can be found
at http://www.exac.com.
*The ExactechGPS is intended for use during preoperative
planning and during stereotaxic surgery to aid the surgeon in
locating anatomical structures and aligning the endoprostheses with
the anatomical structures.
1Hopkins AR, Hansen UN, Amis AA, Emery R. The Effects of Glenoid
Component Alignment Variations on Cement Mantle Stresses in Total
Shoulder Arthroplasty. J Shoulder Elbow Surgery. 2004 Nov-Dec;
13(6):668–675.
2Gregory TM, Sankey A, Augereau B, et al. Accuracy of Glenoid
Component Placement in Total Shoulder Arthroplasty and Its Effect
on Clinical and Radiological Outcome in a Retrospective,
Longitudinal, Monocentric Open Study. PLoS ONE. 2013 Oct;
8(10):e75791.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160929006357/en/
Exactech, Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance &Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888EXAC@hawkassociates.comorMedia contactPriscilla
Bennett, 352-377-1140Vice President, Corporate & Marketing
Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2024 to May 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From May 2023 to May 2024